Alnylam downgraded at Bernstein on TRITON-CM trial design

Alnylam Pharmaceuticals (ALNY) stock slips as Bernstein downgrades the company to Market Perform from Outperform. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real